Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
C. Bouchard, F. Labrie, D. F. Archer, D. J. Portman, W. Koltun, É. Elfassi, D. A. Grainger, N. Ayotte, T. A. Cooper, M. Martens, A. S. Waldbaum, C. Labrie, I. Côté, L. Lavoie, C. Martel & J. Balser. (2015) Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy. Climacteric 18:4, pages 590-607.
Read now
Read now
Svetlana Dragojevic Dikic, Ana Mitrovic Jovanovic, Srdjan Dikic, Tomislav Jovanovic, Aleksandar Jurisic & Aleksandar Dobrosavljevic. (2015) Melatonin: a “Higgs boson” in human reproduction. Gynecological Endocrinology 31:2, pages 92-101.
Read now
Read now
F. Labrie & C. Labrie. (2013) DHEA and intracrinology at menopause, a positive choice for evolution of the human species. Climacteric 16:2, pages 205-213.
Read now
Read now
F. Labrie, D. F. Archer, C. Bouchard, M. Fortier, L. Cusan, J.-L. Gomez, G. Girard, M. Baron, N. Ayotte, M. Moreau, R. Dubé, I. Côté, C. Labrie, L. Lavoie, L. Berger, L. Gilbert, C. Martel & J. Balser. (2011) Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia. Climacteric 14:2, pages 282-288.
Read now
Read now
M. A. Duzenli, K. Ozdemir, A. Sokmen, K. Gezginc, A. Soylu, C. Celik, B. B. Altunkeser & M. Tokac. (2010) The effects of hormone replacement therapy on myocardial performance in early postmenopausal women. Climacteric 13:2, pages 157-170.
Read now
Read now
A. H. MacLennan, T. K. Gill, J. L. Broadbent & A. W. Taylor. (2009) Continuing decline in hormone therapy use: population trends over 17 years. Climacteric 12:2, pages 122-130.
Read now
Read now
M. H. Birkhäuser & I. Reinecke. (2008) Current trends in hormone replacement therapy: perceptions and usage. Climacteric 11:3, pages 192-200.
Read now
Read now
Manuel Neves-e-Castro. (2007) When a dream comes through…. Gynecological Endocrinology 23:8, pages 433-435.
Read now
Read now
Articles from other publishers (14)
Sunita Malik, Deepika Pannu, Shashi Prateek, Renuka Sinha & Harsha Gaikwad. (2016) Comparison of the symptomatic response in Indian menopausal women with different estrogen preparations for the treatment of menopausal symptoms: a randomized controlled trial. Archives of Gynecology and Obstetrics 293:6, pages 1325-1333.
Crossref
Crossref
Fernand Labrie, David F. Archer, Céline Bouchard, Ginette Girard, Normand Ayotte, John C. Gallagher, Leonello Cusan, Mira Baron, François Blouin, Arthur S. Waldbaum, William Koltun, David J. Portman, Isabelle Côté, Lyne Lavoie, Adam Beauregard, Claude Labrie, Céline Martel, John Balser & Érick Moyneur. (2015) Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas 81:1, pages 46-56.
Crossref
Crossref
Fernand Labrie. (2015) All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause. The Journal of Steroid Biochemistry and Molecular Biology 145, pages 133-138.
Crossref
Crossref
Fernand Labrie. 2011. DHEA in Human Health and Aging. DHEA in Human Health and Aging
153
172
.
Fernand Labrie, Céline Martel & John Balser. (2011) Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women. Menopause 18:1, pages 30-43.
Crossref
Crossref
Fernand Labrie. (2010) Intravaginal DHEA, by a strictly local action, exerts beneficial effects on both vaginal atrophy symptoms and sexual dysfunction. Hormone Molecular Biology and Clinical Investigation 4:1.
Crossref
Crossref
Fernand Labrie. 2010. Neuroendocrinology - Pathological Situations and Diseases. Neuroendocrinology - Pathological Situations and Diseases
97
148
.
Dirk Wildemeersch. 2010. Drug Delivery. Drug Delivery
267
298
.
Barry G Wren. (2009) The benefits of oestrogen following menopause: why hormone replacement therapy should be offered to postmenopausal women. Medical Journal of Australia 190:6, pages 321-325.
Crossref
Crossref
J. Berdah & G. Amah. (2009) Les facteurs de risque cardiovasculaires concernent aussi les femmes… rôle du gynécologue. Gynécologie Obstétrique & Fertilité 37:2, pages 186-193.
Crossref
Crossref
Alastair H. MacLennan. (2009) Hormone replacement therapy: a 2008 perspective. Obstetrics, Gynaecology & Reproductive Medicine 19:1, pages 13-18.
Crossref
Crossref
I E Chazova, V P Smetnik, V E Balan, Ya Z Zaydieva, E Yu Maychuk, V B Mychka, A A Kirichenko, V I Podzolkov, N M Podzolkova & S V Yureneva. (2008) Vedenie zhenshchin s serdechno-sosudistym riskom v peri- i postmenopauze: konsensus rossiyskikh kardiologov i ginekologov. Systemic Hypertension 5:3, pages 26-39.
Crossref
Crossref
M. Sara Rosenthal. (2008) The Wiley Protocol. Menopause 15:5, pages 1014-1022.
Crossref
Crossref
Régine Sitruk-Ware. (2007) Does estrogen therapy reduce coronary artery calcification in postmenopausal women?. Nature Clinical Practice Endocrinology & Metabolism 4:1, pages 12-13.
Crossref
Crossref